Exploring the clinicopathological parameters of HER2 low breast cancers: insights from a retrospective cohort study
This study underscores the complexity of HER2 low breast cancer and its implications for clinical management, emphasizing the need for personalized treatment strategies. It provides insights into the clinicopathological parameters of HER2 low breast cancers, highlighting their diverse characteristics and clinical implications.
Authors
- Adil Aziz Khan (ORCID: https://orcid.org/0000-0002-0882-558X)
- Sufian Zaheer (ORCID: https://orcid.org/0000-0002-8044-4327)
- Sana Ahuja (ORCID: https://orcid.org/0000-0002-4630-016X)
- G Kiruthikasri
Institutions
- Vardhman Mahavir Medical College & Safdarjung Hospital (IN)
Publication Details
- Journal
- Korean Journal of Clinical Oncology
- Published
- 2024-12-30
- DOI
- https://doi.org/10.14216/kjco.24011
- Primary Topic
- HER2/EGFR in Cancer Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00